vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and SunOpta Inc. (STKL). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $205.4M, roughly 1.2× SunOpta Inc.). SunOpta Inc. runs the higher net margin — 0.4% vs -35.0%, a 35.4% gap on every dollar of revenue. On growth, SunOpta Inc. posted the faster year-over-year revenue change (16.6% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $12.1M). Over the past eight quarters, SunOpta Inc.'s revenue compounded faster (7.4% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.
CCRN vs STKL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $205.4M |
| Net Profit | $-82.9M | $816.0K |
| Gross Margin | — | 12.4% |
| Operating Margin | -30.2% | 3.3% |
| Net Margin | -35.0% | 0.4% |
| Revenue YoY | -23.6% | 16.6% |
| Net Profit YoY | -2109.7% | 113.1% |
| EPS (diluted) | $-2.56 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | — | ||
| Q3 25 | $250.1M | $205.4M | ||
| Q2 25 | $274.1M | $191.5M | ||
| Q1 25 | $293.4M | $201.6M | ||
| Q4 24 | $309.9M | $193.9M | ||
| Q3 24 | $315.1M | $175.9M | ||
| Q2 24 | $339.8M | $169.5M | ||
| Q1 24 | $379.2M | $184.4M |
| Q4 25 | $-82.9M | — | ||
| Q3 25 | $-4.8M | $816.0K | ||
| Q2 25 | $-6.7M | $4.4M | ||
| Q1 25 | $-490.0K | $4.8M | ||
| Q4 24 | $-3.8M | $-8.7M | ||
| Q3 24 | $2.6M | $-6.2M | ||
| Q2 24 | $-16.1M | $-5.3M | ||
| Q1 24 | $2.7M | $2.9M |
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | 12.4% | ||
| Q2 25 | 20.4% | 14.8% | ||
| Q1 25 | 20.0% | 15.0% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | 20.4% | 13.0% | ||
| Q2 24 | 20.8% | 12.5% | ||
| Q1 24 | 20.4% | 16.8% |
| Q4 25 | -30.2% | — | ||
| Q3 25 | -2.4% | 3.3% | ||
| Q2 25 | -2.1% | 5.5% | ||
| Q1 25 | -0.3% | 5.2% | ||
| Q4 24 | -1.1% | 1.4% | ||
| Q3 24 | 0.9% | 0.5% | ||
| Q2 24 | -5.7% | 1.2% | ||
| Q1 24 | 0.8% | 5.5% |
| Q4 25 | -35.0% | — | ||
| Q3 25 | -1.9% | 0.4% | ||
| Q2 25 | -2.4% | 2.3% | ||
| Q1 25 | -0.2% | 2.4% | ||
| Q4 24 | -1.2% | -4.5% | ||
| Q3 24 | 0.8% | -3.5% | ||
| Q2 24 | -4.7% | -3.1% | ||
| Q1 24 | 0.7% | 1.6% |
| Q4 25 | $-2.56 | — | ||
| Q3 25 | $-0.15 | $0.01 | ||
| Q2 25 | $-0.20 | $0.03 | ||
| Q1 25 | $-0.02 | $0.04 | ||
| Q4 24 | $-0.13 | $-0.08 | ||
| Q3 24 | $0.08 | $-0.05 | ||
| Q2 24 | $-0.47 | $-0.04 | ||
| Q1 24 | $0.08 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $2.2M |
| Total DebtLower is stronger | — | $250.8M |
| Stockholders' EquityBook value | $322.8M | $162.8M |
| Total Assets | $449.0M | $694.1M |
| Debt / EquityLower = less leverage | — | 1.54× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | — | ||
| Q3 25 | $99.1M | $2.2M | ||
| Q2 25 | $81.2M | $2.2M | ||
| Q1 25 | $80.7M | $2.3M | ||
| Q4 24 | $81.6M | $1.6M | ||
| Q3 24 | $64.0M | $2.9M | ||
| Q2 24 | $69.6M | $3.2M | ||
| Q1 24 | $5.2M | $1.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $250.8M | ||
| Q2 25 | — | $263.3M | ||
| Q1 25 | — | $260.6M | ||
| Q4 24 | — | $265.2M | ||
| Q3 24 | — | $289.9M | ||
| Q2 24 | — | $303.1M | ||
| Q1 24 | — | $258.8M |
| Q4 25 | $322.8M | — | ||
| Q3 25 | $408.1M | $162.8M | ||
| Q2 25 | $412.2M | $159.8M | ||
| Q1 25 | $418.2M | $154.8M | ||
| Q4 24 | $419.0M | $148.6M | ||
| Q3 24 | $424.7M | $155.0M | ||
| Q2 24 | $433.3M | $158.8M | ||
| Q1 24 | $462.4M | $163.6M |
| Q4 25 | $449.0M | — | ||
| Q3 25 | $538.2M | $694.1M | ||
| Q2 25 | $553.8M | $704.9M | ||
| Q1 25 | $576.2M | $690.7M | ||
| Q4 24 | $589.3M | $668.5M | ||
| Q3 24 | $597.4M | $699.3M | ||
| Q2 24 | $602.9M | $704.7M | ||
| Q1 24 | $648.4M | $671.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.54× | ||
| Q2 25 | — | 1.65× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | — | 1.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $16.3M |
| Free Cash FlowOCF − Capex | $16.1M | $12.1M |
| FCF MarginFCF / Revenue | 6.8% | 5.9% |
| Capex IntensityCapex / Revenue | 0.9% | 2.1% |
| Cash ConversionOCF / Net Profit | — | 20.03× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $36.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | — | ||
| Q3 25 | $20.1M | $16.3M | ||
| Q2 25 | $4.2M | $-4.5M | ||
| Q1 25 | $5.7M | $22.3M | ||
| Q4 24 | $24.2M | $33.1M | ||
| Q3 24 | $7.5M | $17.2M | ||
| Q2 24 | $82.4M | $-5.6M | ||
| Q1 24 | $6.0M | $5.3M |
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | $12.1M | ||
| Q2 25 | $2.3M | $-9.2M | ||
| Q1 25 | $3.8M | $9.5M | ||
| Q4 24 | $21.7M | $24.0M | ||
| Q3 24 | $6.3M | $11.7M | ||
| Q2 24 | $79.6M | $-15.3M | ||
| Q1 24 | $3.8M | $-2.3M |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | 5.9% | ||
| Q2 25 | 0.8% | -4.8% | ||
| Q1 25 | 1.3% | 4.7% | ||
| Q4 24 | 7.0% | 12.4% | ||
| Q3 24 | 2.0% | 6.6% | ||
| Q2 24 | 23.4% | -9.0% | ||
| Q1 24 | 1.0% | -1.2% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | 2.1% | ||
| Q2 25 | 0.7% | 2.5% | ||
| Q1 25 | 0.6% | 6.3% | ||
| Q4 24 | 0.8% | 4.7% | ||
| Q3 24 | 0.4% | 3.2% | ||
| Q2 24 | 0.8% | 5.7% | ||
| Q1 24 | 0.6% | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 20.03× | ||
| Q2 25 | — | -1.03× | ||
| Q1 25 | — | 4.63× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | 1.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
STKL
| Beverages And Broths | $161.4M | 79% |
| Fruit Snacks | $40.9M | 20% |
| Ingredients | $3.1M | 2% |
